Should a biotech hand its molecule to a single integrated partner, or build a network of specialists around it? Manufacturers and clinical providers are answering in both directions at once: some are ...
Key Takeaways This week a Washington Post opinion piece described asking Google‘s Gemini about a former high school music ...
NIAID-RNCP elects to evaluate the efficacy of Entolimod on gastrointestinal acute radiation syndrome ("GI-ARS"), after the ...
Researchers show that lexical and embedding-based drift measures between synthetic and real clinical text moderately predict ...
Chicago-based financial-services firm details how machine learning, multi-factor modeling and cross-border risk ...
Pharmaceutical Technology on MSN
Formation Bio launches $600m drug development fund
Formation Bio plans to source Phase I and Phase II assets from biotechnology and pharmaceutical companies.
Latus Bio, Inc. (Latus), a biotechnology company engineering gene therapies at scale, today announced the publication of a ...
A simulation study reports that a bio-inspired, AI-enabled wireless sensor network design improved network lifetime, energy ...
Sword Bio and Alturas Analytics today announced a strategic collaboration designed to provide biotechnology and pharmaceutical ...
MitoCareX considers preliminary, not yet experimentally validated, computational findings encouraging for further computational analysis and ...
Block's in-house AI research lab announced Dessa on October 23, 2026, a full-duplex speech-to-speech model the company says was trained from scratch on nothing but human conversation, releasing live ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results